search
Back to results

PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients (PREVENTIHS)

Primary Purpose

Hemorrhagic Stroke, Venous Thromboembolism, Deep Venous Thrombosis

Status
Terminated
Phase
Phase 3
Locations
Italy
Study Type
Interventional
Intervention
Enoxaparin
Graduated compression stockings and/or intermittent pneumatic compression and/or early mobilization
Sponsored by
University Of Perugia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hemorrhagic Stroke focused on measuring hemorrhagic stroke, venous thromboembolism, prevention

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Intracranial spontaneous hemorrhage on brain CT scan
  • Intracranial hemorrhage during treatment with oral anticoagulants
  • Bedridden patients (item 6 of NIHSS: motor leg points 3 or 4 or severe ataxia for cerebellar hemorrhage).

Exclusion Criteria:

  • cerebral hemorrhage due to intracranial vascular malformation
  • rebleeding on CT scan after 72 hours from stroke (before randomization)

Sites / Locations

  • Stroke Unit

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

low weight molecular heparin

standard therapy

Arm Description

enoxaparin 0.4 ml subcutaneous per day

Graduated compression stockings and/or intermittent pneumatic compression and/or early mobilization

Outcomes

Primary Outcome Measures

Number of Participants With Symptomatic and Asymptomatic Venous Thromboembolism
Symptomatic venous thromboembolism (deep venous thrombosis and/or pulmonary embolism) and asymptomatic deep venous thrombosis on ultrasound examination

Secondary Outcome Measures

Bleedings
symptomatic and asymptomatic intra and extracranial bleedings
Mortality
mortality of any cause
Disability
modified Rankin Scale (mRS) equal to and greater than 3. 0 - No symptoms. - No significant disability. Able to carry out all usual activities, despite some symptoms. - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. - Moderate disability. Requires some help, but able to walk unassisted. - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. - Severe disability. Requires constant nursing care and attention, bedridden, incontinent. - Dead.

Full Information

First Posted
March 31, 2012
Last Updated
September 9, 2021
Sponsor
University Of Perugia
search

1. Study Identification

Unique Protocol Identification Number
NCT01573169
Brief Title
PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients
Acronym
PREVENTIHS
Official Title
PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Terminated
Why Stopped
The trial has been terminated prematurely after the randomization of 73 patients due to a lack of funding.
Study Start Date
May 2012 (undefined)
Primary Completion Date
March 2020 (Actual)
Study Completion Date
March 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Of Perugia

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Patients with cerebral hemorrhage (ICH) have a high risk of venous thromboembolism. Intermittent pneumatic compression combined with elastic stockings have been shown to be superior to elastic stockings alone in reducing the rate of asymptomatic deep vein thrombosis after ICH in a randomized trial (4.7% vs. 15.9%). Graduated compression stockings alone are ineffective in preventing deep vein thrombosis in patients with ischemic or hemorrhagic stroke. Less clear is the role of anticoagulation in the prevention of venous thromboembolism in patients with ICH because the use of anticoagulants may cause an enlargement of the hematoma. In a multicenter, randomized trial, the investigators will assess the efficacy and safety of enoxaparin in the prevention of venous thromboembolism in patients with spontaneous intracerebral hemorrhage. Enoxaparin (40 mg once daily) or standard therapy (graduated compression stockings and/or intermittent pneumatic compression and/or early mobilization) will be given subcutaneously for not less than 10 days beginning after 72 hours from stroke onset.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hemorrhagic Stroke, Venous Thromboembolism, Deep Venous Thrombosis
Keywords
hemorrhagic stroke, venous thromboembolism, prevention

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
73 (Actual)

8. Arms, Groups, and Interventions

Arm Title
low weight molecular heparin
Arm Type
Experimental
Arm Description
enoxaparin 0.4 ml subcutaneous per day
Arm Title
standard therapy
Arm Type
Placebo Comparator
Arm Description
Graduated compression stockings and/or intermittent pneumatic compression and/or early mobilization
Intervention Type
Drug
Intervention Name(s)
Enoxaparin
Intervention Description
enoxaparin 0.4 ml sc per day for 10 days started 72 hours after the stroke
Intervention Type
Other
Intervention Name(s)
Graduated compression stockings and/or intermittent pneumatic compression and/or early mobilization
Intervention Description
placebo standard therapy
Primary Outcome Measure Information:
Title
Number of Participants With Symptomatic and Asymptomatic Venous Thromboembolism
Description
Symptomatic venous thromboembolism (deep venous thrombosis and/or pulmonary embolism) and asymptomatic deep venous thrombosis on ultrasound examination
Time Frame
10 days
Secondary Outcome Measure Information:
Title
Bleedings
Description
symptomatic and asymptomatic intra and extracranial bleedings
Time Frame
90 days
Title
Mortality
Description
mortality of any cause
Time Frame
90 days
Title
Disability
Description
modified Rankin Scale (mRS) equal to and greater than 3. 0 - No symptoms. - No significant disability. Able to carry out all usual activities, despite some symptoms. - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. - Moderate disability. Requires some help, but able to walk unassisted. - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. - Severe disability. Requires constant nursing care and attention, bedridden, incontinent. - Dead.
Time Frame
90 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Intracranial spontaneous hemorrhage on brain CT scan Intracranial hemorrhage during treatment with oral anticoagulants Bedridden patients (item 6 of NIHSS: motor leg points 3 or 4 or severe ataxia for cerebellar hemorrhage). Exclusion Criteria: cerebral hemorrhage due to intracranial vascular malformation rebleeding on CT scan after 72 hours from stroke (before randomization)
Facility Information:
Facility Name
Stroke Unit
City
Perugia
ZIP/Postal Code
06126
Country
Italy

12. IPD Sharing Statement

Citations:
PubMed Identifier
21324058
Citation
Paciaroni M, Agnelli G, Venti M, Alberti A, Acciarresi M, Caso V. Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage: a meta-analysis of controlled studies. J Thromb Haemost. 2011 May;9(5):893-8. doi: 10.1111/j.1538-7836.2011.04241.x.
Results Reference
background
PubMed Identifier
33190135
Citation
Paciaroni M, Agnelli G, Alberti A, Becattini C, Guercini F, Martini G, Tassi R, Marotta G, Venti M, Acciarresi M, Mosconi MG, Marcheselli S, Fratticci L, D'Amore C, Ageno W, Versino M, De Lodovici ML, Carimati F, Pezzini A, Padovani A, Corea F, Scoditti U, Denti L, Tassinari T, Silvestrelli G, Ciccone A, Caso V. PREvention of VENous Thromboembolism in Hemorrhagic Stroke Patients - PREVENTIHS Study: A Randomized Controlled Trial and a Systematic Review and Meta-Analysis. Eur Neurol. 2020;83(6):566-575. doi: 10.1159/000511574. Epub 2020 Nov 13.
Results Reference
derived

Learn more about this trial

PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients

We'll reach out to this number within 24 hrs